A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors

Clinical trial NCT06926283 · RECRUITING

Trial details

NCT number: NCT06926283
Sponsor: Hangzhou DAC Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Other Solid Tumors Ewing Sarcoma

Start date: 2025-05-15
Primary completion: 2030-04-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.